Author:
Ryczkowska Małgorzata,Maciejewska Natalia,Olszewski Mateusz,Witkowska Milena,Makowiec Sławomir
Abstract
AbstractThe anticancer properties of quinolones is a topic of interest among researchers in the scientific world. Because these compounds do not cause side effects, unlike the commonly used cytostatics, they are considered a promising source of new anticancer drugs. In this work, we designed a brief synthetic pathway and obtained a series of novel 8-phenyltetrahydroquinolinone derivatives functionalized with benzyl-type moieties at position 3. The compounds were synthesized via classical reactions such as nucleophilic substitution, solvent lysis, and condensation. Biological evaluation revealed that 3-(1-naphthylmethyl)-4-phenyl-5,6,7,8-tetrahydro-1H-quinolin-2-one (4a) exhibited potent cytotoxicity toward colon (HTC-116) and lung (A549) cancer cell lines. Analysis of the mechanism of action of compounds showed that compound 4a induced cell cycle arrest at the G2/M phase, leading to apoptotic cell death via intrinsic and extrinsic pathways. Taken together, the findings of the study suggest that tetrahydroquinolinone derivatives bearing a carbonyl group at position 2 could be potential lead compounds to develop anticancer agents for the treatment of lung cancers.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Renehan, A. G., Booth, C. & Potten, C. S. What is apoptosis, and why is it important?. BMJ 322, 1536–1538 (2001).
2. Sjöström, J. & Bergh, J. How apoptosis is regulated, and what goes wrong in cancer. BMJ 322, 1538–1539 (2001).
3. Jan, R. & Chaudhry, G. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv. Pharm. Bull. 9, 205–218 (2019).
4. Beberok, A. et al. Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/BCL-2 signaling pathway. Int. J. Oncol. 52, 1727–1737 (2018).
5. Beberok, A. et al. Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells. Pharmacol. Rep. 70, 6–13 (2018).